Blocklisting Interim Review
31 Agosto 2005 - 7:10AM
UK Regulatory
RNS Number:6381Q
Biotrace International PLC
31 August 2005
SCHEDULE 5
BLOCKLISTING SIX MONTHLY RETURN
To: Listing Applications
UK Listing Authority
Financial Services Authority
25, The North Colonnade
Canary Wharf
London, E14 5HS
Please ensure the entries on this return are typed
1. Name of company
Biotrace International Plc
2. Name of scheme
Share Option Scheme
3. Period of return:
From 1 February 2005 To 31 August 2005
4. Number and class of share(s) (amount of stock / debt security) not issued
under scheme
431,136
5. Number of shares issued / allotted under scheme during period:
Nil
6. Balance under scheme not yet issued / allotted at end of period
431,136
7. Number and class of share(s) (amount of stock / debt securities) originally
listed and the date of admission;
1,000,000 Ordinary Shares of 10p
28 November 2000
Please confirm total number of shares in issue at the end of the period in order
for us to update our records
38,865,149
Contact for queries
Name
Peter Morgan
Telephone
01656 641 400
Person making the return
Name
Peter Morgan
Position
Finance Director
Signature
.......................................................
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRPBMMTMMMJBPA
Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Bank Irel13.375 da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Biotrace Int.